(H2) High-Level Overview
BBy is a healthtech startup revolutionizing how hospitals store and administer breast milk, particularly in neonatal intensive care units (NICUs). The company’s proprietary technology condenses donor breast milk into a shelf-stable powder that retains its immunological and nutritional properties for up to six months. This innovation eliminates the need for time-consuming freezing and thawing, freeing nurses from labor-intensive “milk shifts” and reducing waste. BBy currently serves hospitals, delivering powdered milk in aluminum packets for easy reconstitution, and is rapidly scaling its operations across the U.S. With strong growth momentum—approaching $10 million in annual revenue and recently raising $3 million in seed funding—BBy is positioning itself as a new standard in hospital breast milk management.
(H2) Origin Story
BBy was founded in 2015 by Dr. Vansh Langer, a physician with firsthand experience in NICUs, and Dr. Blanca Aguilar Uscanga, a bioengineering and food science expert. The idea emerged when Langer observed the inefficiencies and labor costs associated with traditional breast milk storage in hospitals. The lengthy process of freezing, thawing, and discarding unused milk not only wasted valuable nursing time but also compromised the availability of this critical resource for premature and vulnerable infants. Teaming up with Aguilar Uscanga, Langer set out to develop a solution that could preserve the biological integrity of breast milk while making it easier to store and use. Early traction came from pilot programs with major hospitals, leading to rapid adoption and expansion into regional processing facilities.
(H2) Core Differentiators
- Immunologically Active Powder: BBy’s technology uses a proprietary laser and algorithm to spray-dry breast milk, preserving its bioactive components—unlike traditional methods that degrade nutrients and immune factors.
- Shelf Stability: The resulting powder lasts up to six months without refrigeration, drastically reducing waste and storage costs.
- Hospital-Centric Model: BBy focuses on institutional clients, delivering pre-portioned packets directly to NICUs, streamlining workflow and reducing labor.
- Scalable Processing: The company operates eight regional facilities, processing 10 gallons of milk twice daily, with plans to expand.
- Scientific Backing: Over 50 peer-reviewed studies support BBy’s approach, and its technology is recognized by the FDA as a food device.
(H2) Role in the Broader Tech Landscape
BBy is riding the wave of healthtech innovation aimed at solving systemic inefficiencies in healthcare delivery. The timing is critical: hospitals are under pressure to reduce costs, improve patient outcomes, and optimize staff time. By digitizing and modernizing a 70-year-old process, BBy is part of a broader trend toward “smart” hospital infrastructure and precision nutrition. The company’s success also highlights the growing interest in maternal and infant health as a venture-backed sector, with startups now tackling everything from at-home milk processing to AI-driven lactation support. BBy’s institutional focus sets it apart from consumer-oriented competitors, positioning it as a key player in the future of hospital nutrition.
(H2) Quick Take & Future Outlook
BBy is poised to become the de facto standard for breast milk management in hospitals, with plans to double revenue in the next year and expand its footprint. The company’s future pipeline includes more user-friendly devices for home use, potentially opening up a new consumer market. As healthcare systems continue to prioritize efficiency and patient care, BBy’s technology will likely influence not only NICUs but also broader hospital supply chains and infant nutrition protocols. The startup’s journey reflects a larger shift: the convergence of food science, medical innovation, and operational efficiency in healthtech. Just as powdered milk transformed infant feeding in the 20th century, BBy may be setting the stage for a new era of shelf-stable, biologically active nutrition in the 21st.
